Prolactin changes as a consequence of chemical exposure [3]

Environmental Health Perspectives

Volumn 114, Issue 10, 2006, Pages

  Alessio, Lorenzo ^a   Lucchini, Roberto ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ANESTHETIC GAS; BIOLOGICAL MARKER; CADMIUM; ENVIRONMENTAL CHEMICAL; LEAD; MANGANESE; NEUROTOXIN; NEUROTRANSMITTER; ORGANOMERCURY COMPOUND; PESTICIDE; POLYCHLORINATED BIPHENYL; PROLACTIN; STYRENE; TETRACHLOROETHYLENE;

DIETARY INTAKE; DOPAMINERGIC SYSTEM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL PROTECTION; FOOD CONTAMINATION; HEALTH HAZARD; HORMONAL REGULATION; HUMAN; LETTER; NEUROTOXICITY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; RISK ASSESSMENT; SEROTONINERGIC SYSTEM;

EID: 33749452281     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.114-a573     Document Type: Letter

References (25)

1. Alessio L, Apostoli P, Conesi I, Lucchini R, eds. 2002. Assessment of Effects Due to Low Doses of Inorganic Mercury Following Environmental and Occupational Exposure: Human and in Vitro Studies on Specific Toxicity Mechanisms. Med Lav 93(3).
2. Alessio L, Apostoli P, Ferioli A, Di Sipto I, Mussi I, Rigosa C, et al. 1989. Behaviour of biological indicators of internal dose and some neuro-endocrine tests in aluminium workers. Med Lav 80:290-300.
3. Beliles RP. 2002. Concordance across species in the reproductive and developmental toxicity of tetrachloroethylene. Toxicol Ind Health 18:91-106.
4. Bergamaschi E, Mutti A, Cavazzinni S, Vettori MV, Renzulli FS, Franchini I. 1996. Peripheral markers of neurochemical effects among styrene-exposed workers. Neurotoxicol 17:753-759.
5. Calderoni AM, Oliveros L, Jahn G, Anton R, Luco J, Gimenez MS. 2005. Alterations in the lipid content of pituitary gland and serum prolactin and growth hormone in cadmium treated rats. Biometals 18:213-220.
6. Carta P, Flore C, Alinovi R, Ibba A, Tocco MG, Aru G, et al. 2003. Sub-clinical neurobehavioral abnormalities associated with low level of mercury exposure through fish consumption Neurotoxicolog 24:617-623.
7. de Burbure C, Buchet JP, Leroyer A, Nisse C, Haguenoer JM, Mutti A, et al. 2006. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ Health Perspect 114:584-590.
8. Do Krey GK, Hollingshead NC, Kerkvliet NI, Smith BB. 1994. Suppression of prolactin and cytotoxic T-lymphocyte activity in PCB-treated mice. Int J Immunopharmacol 16:251-257.
9. Ellingsen DG, Haug E, Gaarder PI, Bast-Petterson R, Thomassen Y. 2003. Endocrine and immunologic markers in manganese alloy production workers. Scand J Work Environ Health 29:230-238.
10. Ferroni C, Selis L, Mutti A, Folli D, Bergamaschi E, Franchini I. 1992. Neurobehavioral and neuroandocrine effects of occupational exposure to perchloroethylene. Neurotoxicology 13:243-247.
11. Govoni S, Battaini F, Fernicola C, Castelletti L, Trabucchi M. 1987. Plasma prolactin concentrations in lead exposed workers. J Environ Pathol Toxicol Oncol 7:13-15
12. Lafuente A, Cano P, Esquifino A. 2003. Are cadmium effects on plasma gonadotropins, prolactin, ACTH, GH and TSH levels, dose-dependent? Biometals 16:243-250.
13. Lucchini R, Albini E, Cortesi I, Placidi D, Bergamaschi E, Traversa F, et al. 2000, Assessment of neurobehavioral performance as a function of current and cumulative occupational lead exposure. Neurotoxicology 21:805-811.
14. Lucchini R, Calza S, Camerino D, Carta P, Decarli A, Parrinello G, et al. 2003. Applicalion of a latent variable model for a multi-center study on early effects due to mercury exposure. Neurotoxicology. 24(4-5):605-616.
15. Lucchini R, Placidi D, Toffoletto F, Alesssio L 1996. Neurotoxicky in operating room personnel working with gaseous and non-gaseous anesthesia. Int Arch Occup Environ Health 68:188-192.
16. Luderer U, Tornero-Velez R, Shay T, Rappaport S, Heyer N, Echeverria D. 2004. Temporal association between serum prolactin concentration and exposure to styrene. Occup Environ Med 61:325-333.
17. Marana E, Annetta MG, Mea F, Parpaglioni R, Galeone M, Maussier ML, et al. 2003. Sevoflurane improves the neuroendocrine stress response during laparoscopic pelvic surgery. Can J Anaesth 50:348-354.
18. Mutti A, Smargiassi A. 1998. Selective vulnerability of dopaminergic systems to industrial chemicals: risk assessment of related neuroendocrine changes. Toxicol Ind Health 14:311-323.
19. Myers JE, Thompson ML, Naik I, Theodorou P, Esswein E, Tassell H, et al. 2003. The utility of biological monitoring for manganese in ferroalloy smelter workers in South Africa. Neurotoxicolog 24:875-883.
20. Ramalingam V, Vimaladevi V, Rajeswary S, Suryavathi V. 2003. Effect of mercuric chloride on circulating hormones in adult albino rats. J∞Environ Biol 24:401-404.
21. Roels HA, Ghyselen P, Buchet JP, Ceulemans E, Lauwerys RR. 1992. Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med 49(1):25-34.
22. Smargiassi A, Mutti A. 1999. Peripheral biomarkers and exposure to manganese. Neurotoxicology 20:401-406.
23. Takser L, Mergler D, de Grosbois S, Smargiassi A, Lafond J. 2004. Blood manganese content at birth and cord serum prolactin levels. Neurotoxicol Teratol 26:811-815.
24. Umemura T, Kurahashi N, Kondo T, Katakura Y, Sata F, Kawai T, et al. 2005. Acute effects of styrene inhalation on the neuroendocrinological system of rats and the different effects in male and female rats. Arch Toxicol 79:653-659; doi:10.1007/s00204-005-0684-2 [Online I5 JuIy 2005].
25. U. S. EPA. 2002. A Review of the Reference Dose and Reference Concentration Processes. EPA/630/P-02/002F. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.cpa.gov/IRIS/ RFD_FINAL%5B1%50.pdf [accessed 15 May 2006].